Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Ultra Regimen Comparison in Dry Eye
NCT02446015Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jun 2015
- Primary completion
- Jun 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
A Phase 4 trial of hydroxypropyl-guar + polyethylene glycol 400 + propylene glycol in dry eye syndrome (DED), sponsored by Alcon Inc.. Started Jun 2015; status: completed.
02
Drugs
hydroxypropyl-guar + polyethylene glycol 400 + propylene glycol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02446015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446015.